Legend Biotech (LEGN) Change in Taxes (2019 - 2023)
Legend Biotech (LEGN) reported Change in Taxes of $128000.0 for Q2 2023, down 96.69% on a YoY basis from $3.9 million in Q2 2022, and up 200.0% quarter-over-quarter from -$128000.0 in Q1 2023.
Legend Biotech (LEGN) Change in Taxes (2019 - 2023) Analysis & Trends
Legend Biotech has reported Change in Taxes for 5 years, with the latest figure at $128000.0 in Q2 2023.
- For the quarter ending Q2 2023, Change in Taxes fell 96.69% year-over-year to $128000.0; the trailing twelve-month figure through Sep 2023 stood at $3.7 million (down 13.06% YoY), and the FY2022 full-year result was -$625000.0, down 117.29% from the prior year.
- Change in Taxes for Q2 2023 stood at $128000.0, up from -$128000.0 in the prior quarter.
- The five-year high for Change in Taxes was $3.9 million in Q2 2022, with the low at -$2.3 million in Q4 2019.
- Historically, Change in Taxes has averaged $484756.8 across 5 years, with a median of $1541.0 in 2021.
- The largest YoY upside for Change in Taxes was 387300.0% in 2022 against a maximum downside of 4093.14% in 2022.
- Legend Biotech's Change in Taxes stood at -$2.3 million in 2019, then jumped by 96.82% to -$72000.0 in 2020, then soared by 873.61% to $557000.0 in 2021, then jumped by 565.89% to $3.7 million in 2022, then sank by 96.55% to $128000.0 in 2023.
- The last three Change in Taxes figures came in at $128000.0 (Q2 2023), -$128000.0 (Q1 2023), and $3.7 million (Q4 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 128,000.00 |
| Jun 30, 2023 | 128,000.00 |
| Mar 31, 2023 | -128,000.00 |
| Mar 31, 2023 | -128,000.00 |
| Dec 31, 2022 | 3.71 Mn |
| Dec 31, 2022 | 3.71 Mn |
| Jun 30, 2022 | 3.87 Mn |
| Jun 30, 2022 | 3.87 Mn |
| Mar 31, 2022 | -163,000.00 |
| Mar 31, 2022 | -163,000.00 |
| Dec 31, 2021 | 557,000.00 |
| Dec 31, 2021 | 557,000.00 |
| Jun 30, 2021 | -1,000.00 |
| Jun 30, 2021 | -1,000.00 |
| Mar 31, 2021 | 4,082.00 |
| Mar 31, 2021 | 4,082.00 |
| Dec 31, 2020 | -72,000.00 |
| Dec 31, 2020 | -72,000.00 |
| Sep 30, 2020 | 508,000.00 |
| Sep 30, 2020 | 508,000.00 |